期刊文献+

77例慢性心力衰竭住院病例药物治疗分析

Analysis on the medical therapy in 77 cases of hospitalized patients with chronic heart failure
下载PDF
导出
摘要 目的:评估循证医学心血管疾病成果是否普及到小城市医疗中心。方法:采用回顾性住院病例77例分析,按年度统计对比。结果:77例次慢性心力衰竭(CHF)患者药物治疗仍以传统治疗为主,ACE抑制剂应用大幅度提高,β-受体阻滞剂应用极少,醛固酮拮抗剂未见应用。结论:循证医学成果已影响到小城市医疗中心,但推广范围及力度不够,β-受体阻滞剂是薄弱环节,靶剂量概念仍有待进一步提高。 Objective To evaluate if Evidence Medicine achievments of cardiovascular disease have effected medical entre in twon. Methods To analyse 77 cases of chronic heart failure in our hospital from 1996 and 2002. Results The conventional drugs still dominate the medical therapy for the heart failure,but the use of ACEI increased significantly,the use of β-blocker was rare, no use of aldosterone antagonist. Conclusion Evidence Medicne achievments have effected medical entre in town, but the promoted extension and power are insufficient,the use of β-blocker and aldosterone agtagonist is fragile segment, the concept of baget dose still needs to be improved.
出处 《安徽卫生职业技术学院学报》 2005年第3期31-32,共2页 Journal of Anhui Health Vocational & Technical College
关键词 心力衰竭 药物治疗 循证医学 heart failure medical therapy Evidence Medicine
  • 相关文献

参考文献3

二级参考文献13

  • 1Kalon KL,Joan LP, William BK. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22 (Suppl A):6A-13A.
  • 2Hung YT, Cheug NT, Ip S. Epidemiology of heart failure in Hong Kong,1997. Hong Kong Med J, 2000,6:159-162.
  • 3Packer M, Coats AJS, Fowler MB, et al. For the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effects of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651-1658.
  • 4Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J, 2001, 22: 1527-1561.
  • 5Hunt HA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the international society for heart and lung transplantation. Circulation, 2001, 104:2996-3007.
  • 6Elkayam U,Weber L,McKay C,et al.Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydraltzine in chronic refractory congestive heart failure[].The American Journal of Cardiology.1984
  • 7Elkayam U,Amin J,Mehra A,et al.A prospective, randomized,double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure[].Circulation.1990
  • 8Elkayam U,Weber L,McKay C,et al.Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure[].The American Journal of Cardiology.1985
  • 9Cheophas TJ,van Marum R.Mata-alalysis of efficacy and safety of second-generation dihydropyridine calcium channel blockers in heart failure[].The American Journal of Cardiology.2001
  • 10Elkayam U,Gleicher N.Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure[].The American Journal of Cardiology.1984

共引文献372

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部